Abstract:Multidrug resistance in tumor cells poses a major obstacle to efficient chemotherapy. Several types of agents have been recognized as multidrug resistance inhibitors, among which the tetrahydroisoquinolines is the most studied. In current study 16 furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline were synthesized. Their cytotoxic activities and effects in reversing multidrug resistance have been evaluated. The results revealed that these compounds had moderate cytotoxic effects. Compounds 7a-f, 7h, and 7l showed higher cytotoxicities than the rest, but lower than adriamycin on K562 cell line. Compounds 7d, 7f, and 7l exhibited potent MDR reversal activities on K562/A02 cell line. The accumulation assay indicated that compounds 7d, 7f, and 7l significantly increased the intracellular accumulation of rhodamine123 in K562/A02 cells. Furthermore, these three compounds produced high concentrations of NO in K562/A02 cells. Potentially, the high concentrations of NO produced by NO donor moieties will lead to an increased cytotoxicity to K562/A02 cells. Our results suggested that compounds 7d, 7f, and 7l had anticancer effects, as well as multidrug resistance reversal effects.

Synthesis and Antitumor Activity of Nitric Oxide Releasing Derivatives of AT1 Antagonist

Synthesis and Biological Evaluations of Novel Nitric Oxide-donating Derivatives of [1,2,4]triazol-5(4H)-one with N-phenylpyrrolyl-2-tetrazole Moiety as Anti-hypertension Candidates

Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin As Potential Anti-Tumor Agents.

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1h-[1,2,4]triazol-5(4h)-one Derivatives As Anti-Hypertension Drugs

Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline As Anticancer and Multidrug Resistance Reversal Agents

Synthesis of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of 1-Oxo-oridonin with Anti-Proliferative Activity

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Sixalkoxyl Biphenyl Derivatives As Anticancer Agents

Synthesis and Evaluation of Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid As Anti-Tumor Agents.

Design, Synthesis and Pharmacological Evaluation of Novel NO-Releasing Benzimidazole Hybrids as Potential Antihypertensive Candidate.

Synthesis and Anti-Lung Cancer Activity of Nitric Oxide-Donating Derivatives of Farnesylthiosalicylic Acid

Synthesis and Antitumor Activity of Nitric Oxide-Donating Glycyrrhetinic Acid Derivatives Coupled with Nitrate Moiety

Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives As Potent Antitumor Agents

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Design, synthesis and cytotoxic evaluation of nitric oxide‐releasing derivatives of isosteviol

Study on NO-donating antihypertensive agents I. Synthesis and antihypertensive activity of C-3 nitrate or furoxan substituted benzopyrans

Synthesis And Biological Activities Of 4-Substituted-3-Alky-4,5-Dihydro-1-(3-Chloro-4-Fluorophenyl)-1,2,4-Triaz Ol-5-One Derivatives

Study on NO-Donating Antihypertensive AgentsI. Synthesis and Antihypertensive Activity of C-3 Nitrate or Furoxan Substituted Benzopyrans

Novel Nitric Oxide-Releasing Isochroman-4-one Derivatives: Synthesis and Evaluation of Antihypertensive Activity.

Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies.

Design, Synthesis, and Biological Evaluation of 1,2,4-Triazole Bearing 5-Substituted Biphenyl-2-sulfonamide Derivatives As Potential Antihypertensive Candidates

Novel NO-releasing Derivatives of Betulinic Acid with Antitumor Activity